Skip to main content
SpringerLink
Log in

Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Prostacyclin and thromboxane production was measured in human umbilical cord arteries bathed in clotting human blood and compared with arteries bathed in Krebs buffer or clotting blood without vessels. In comparison with the combined system, vessels in buffer generated only minute amounts of immunoreactive thromboxane B2 while blood alone generated only minute amounts of immunoreactive 6-oxo-PGF1α. Incubation of vessels in blood was associated with an enhanced 6-oxo-PGF1α formation at 1–2 h of incubation, demonstrating an active prostacyclin synthetase and a transfer of the platelet endoperoxide precursor to this enzyme.

This new combined system was used to reevaluate the selectivity of cyclooxygenase inhibitors for vascular and platelet derived eicosanoid formation. With respect to 6-oxo-PGF1α accumulation, the IC50 value [μmoles/l] for tiaprofenic acid (8.5 ± 3.0) was significantly higher than that for diclofenac (0.14 ± 0.03) (P < 0.05) while acetylsalicylic acid (18.0 ± 7.0) was less potent than diclofenac and indomethacin (2.4 ± 1.0) (P < 0.05). With respect to thromboxane B2 formation, the IC50 values for diclofenac (0.26 ± 0.04), indomethacin (IC50 0.30 ± 0.05) and tiaprofenic acid (IC50 0.71 ± 0.08) were not significantly different from each other. Acetylsalicylic acid (7.7 ± 1.8) was less potent than either of the other compounds (P < 0.01). While these IC50 values might suggest different potencies for inhibition of vascular and platelet cyclooxygenases by tiaprofenic acid and, possibly, indomethacin, statistical analysis was not possible because of different slopes of the dose-response curves. Moreover, a nearly complete inhibition of both enzymes might be expected at therapeutic antiinflammatory plasma levels of the compounds in vivo.

It is concluded that this in vitro system using solely human tissues might be a useful tool to analyse time-dependent alterations in endogenous arachidonate metabolism during blood-vessel wall interactions and its modification by drugs and that this system might be superior to either blood or vessel preparations alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Asai F, Schrör K (1987) Different effects of thromboxane synthetase inhibition on PGI2 and PGE2 synthesis in human vascular tissue bathed in clotting blood. In: Sinzinger H, Schrör K (eds) Prostaglandins in clinical research. Alan R Liss, New York, pp 259–264

    Google Scholar 

  • Bjøro K, Hovig T, Stokke KT, Stray-Pedersen S (1986) Formation of prostanoids in human umbilical vessels perfused in vitro. Prostaglandins 31:683–698

    Google Scholar 

  • Defreyn G, Deckmyn H, Vermylen J (1982) A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2. Thromb Res 26:389–400

    Google Scholar 

  • Feinmark SJ, Cannon JP (1986) Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J Biol Chem 261:16466–16472

    Google Scholar 

  • Fitzpatrick FA, Gorman RR (1977) Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2. Prostaglandins 14:881–889

    Google Scholar 

  • Flower RJ, Moncada S, Vane JR (1985) Drug Therapy of Inflammation. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics. MacMillan Publishing Company, Philadelphia, pp 674–715

    Google Scholar 

  • Hanley SP, Bevan J, Cockbill SR, Heptinstall S (1981) Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet 1:969

    Google Scholar 

  • Jeremy J, Barradas MA, Mikhailidis DP, Dandona P (1985) The effect of tiaprofenic acid and indomethacin on vascular prostacyclin and platelet thromboxane A2 production. Pharmacotherapeutica 4:260–267

    Google Scholar 

  • Kawano M, Mori N (1983) Prostacyclin producing activity of human umbilical, placental and uterine vessels. Prostaglandins 26:645–662

    Google Scholar 

  • Lad N, Lunt DO, Tuffin DP (1987) The effect of thromboxane A2 synthesis inhibitors on platelet aggregation in whole blood. Thromb Res 46:555–566

    Google Scholar 

  • Langer SZ, Trendelenburg U (1969) The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by competitive antagonists. J Pharmacol Exp Ther 16:117–143

    Google Scholar 

  • Lucchesi BR, Mickelson JK, Homeister JW, Jackson CV (1987) Interaction of the formed elements of blood with the coronary vasculature in vivo. Fed Proc 46:63–72

    Google Scholar 

  • McIntyre DE, Pearson JD, Gordon JL (1978) Localization and stimulation of prostacyclin production in vascular cells. Nature 271:549–551

    Google Scholar 

  • Mäkilä U-M, Kokkonen E, Viinika L, Ylikorkala O (1983) Differential inhibition of fetal vascular prostacyclin synthesis by nonsteroidal antiinflammatory drugs in humans. Prostaglandins 25:39–46

    Google Scholar 

  • Marcus AJ, Weksler BB, Jaffe EA, Broekman JM (1980) Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest 66:979–986

    Google Scholar 

  • Mehta J, Mehta P, Lawson DL, Ostrowski N, Brigmon L (1985) Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: Evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. J Lab Clin Med 106:246–252

    Google Scholar 

  • Miller DGK, Sadowski S, Soderman DD, Kuehl FA Jr (1985) Endothelial cell prostacyclin production induced by activated neutrophils. J Biol Chem 260:1006–1014

    Google Scholar 

  • Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Ann Rev Biochem 55:69–102

    Google Scholar 

  • Needleman P, Minkes MS, Raz A (1979) Platelet and blood vessel arachidonate metabolism and interactions. J Clin Invest 63:345–349

    Google Scholar 

  • Patrono C, Ciabattoni G, Pinca E, Pugliese F, Castrucci G, de Salvo A, Satta MA, Peskar BA (1980) Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res 17:317–327

    Google Scholar 

  • Peskar BA, Anhut H, Kröner EE, Peskar BM (1979) Development, specificity and some applications of radioimmunoassays for prostaglandins and related compounds. Adv Pharmacol Ther 7:275–286

    Google Scholar 

  • Philp R, Paul M (1983) Low-dose aspirin renders platelets more vulnerable to inhibition of aggregation by prostacyclin (PGI2). Prostaglandins Leukotrienes Med 11:131–142

    Google Scholar 

  • Pitzke B, Rücker W, Schrör K (1983) Formation of PGI2, PGE2 and TXB2 in whole blood in vitro and its pharmacological modification. Br J Pharmacol 80:700P

    Google Scholar 

  • Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ (1981) Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. New Engl J Med 304:76–79

    Google Scholar 

  • Ritter JM, Ongari MA, Orchard MA, Lewis PJ (1983) Prostacyclin synthesis is stimulated by a serum factor formed during coagulation. Thromb Haemostasis 49:58–60

    Google Scholar 

  • Ritter JM (1984) Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor. Br J Pharmacol 83:409–418

    Google Scholar 

  • Schrör K, Neuhaus V, Ahland B, Sauerland S, Kuhn A, Darius H, Bussmann K (1982) Actions of tiaprofenic acid on vascular prostacyclin biosynthesis and thromboxane and 12-HPETE formation in human platelets in vitro and ex vivo. Rheumatology 7:88–98

    Google Scholar 

  • Schrör K, Sauerland S, Kuhn A, Rösen R (1980) Different sensitivities of prostaglandin cyclooxygenases in blood platelets and coronary arteries against non-steroidal antiinflammatory drugs. Naunyn-Schmiedeberg's Arch Pharmacol 313:69–76

    Google Scholar 

  • Simmet T, Wittenberg HR, Peskar BA (1985) Modulation of eicosanoid release from anaphylactic guinea pig heart with 5-benzoyl-α-methyl-thiophene acetic acid (tiaprofenic acid). Arch Int Pharmacodyn Ther 278:207–214

    Google Scholar 

  • Sorkin EM, Brogden RN (1985) Tiaprofenic acid: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states. Drugs 29:208–235

    Google Scholar 

  • Svensson J, Strandberg K, Tuvemo T, Hamberg M (1977) Thromboxane A2: Effects on airway and vascular smooth muscle. Prostaglandins 14:425–436

    Google Scholar 

  • Thiemermann C, Löbel P, Schrör K (1985) Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage. Am J Cardiol 56:978–982

    Google Scholar 

  • Thorngreen M, Safi S, Born GVR (1983) Tromboxane A2 in skin bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid. Lancet 1:1075–1078

    Google Scholar 

  • Thumb H (1983) Medikamentöse Therapie. In: Mathies H (ed) Handbuch der Inneren Medizin, Rheumatologie A. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Vinge E (1985) Arachidonic acid-induced platelet aggregation and prostanoid formation in whole blood in relation to plasma concentration of indomethacin. Eur J Clin Pharmacol 28:163–169

    Google Scholar 

  • Zaragoza R, Le Breton GC (1987) Effect of single-dose aspirin on TXA2 and PGI2 cyclooxygenases in vivo. Haemostasis 17: 40–48

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie, Universität Düsseldorf, Moorenstrasse 5, D-4000, Düsseldorf 1, Federal Republic of Germany

    Karsten Schrör & Hartmut Seidel

Authors
  1. Karsten Schrör
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hartmut Seidel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schrör, K., Seidel, H. Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system. Naunyn-Schmiedeberg's Arch Pharmacol 337, 177–182 (1988). https://doi.org/10.1007/BF00169246

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169246

Key words

Search

Navigation